Literature DB >> 7566636

Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders.

T Odawara1, E Iseki, K Kosaka, H Akiyama, K Ikeda, T Yamamoto.   

Abstract

An anti-tau monoclonal antibody tau-2 was demonstrated to react with the cells which characteristically appeared in the subcortical nuclei of certain neurodegenerative disorders. These cells had rod-like cell bodies and elongated processes, whose morphology was consistent with that of reactive microglia (tau-2 positive microglia-like cells; TPMC). TPMC were diffusely scattered in the subcortical nuclei, especially the putamen, irrelevant to focal tissue injury such as infarcts and amyloid deposits. TPMC were positively immunostained with anti-ferritin antibody, but negatively with LN3, anti-GFAP, other kinds of anti-tau and anti-neurofilament antibodies. TPMC were found in some cases of Alzheimer type dementia and diffuse Lewy body disease, but not in the cases of Parkinson's disease, Pick's disease and control without neurological disorder. Similar microglia-like cells were found around infarctic foci and amyloid cores of senile plaques, regardless of the disorder. They were, however, different from TPMC in that they were positively immunostained with LN3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566636     DOI: 10.1016/0304-3940(95)11595-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Microglia: Friend and foe in tauopathy.

Authors:  Kristian F Odfalk; Kevin F Bieniek; Sarah C Hopp
Journal:  Prog Neurobiol       Date:  2022-06-14       Impact factor: 10.885

2.  MRI reveals differential effects of amphetamine exposure on neuroglia in vivo.

Authors:  Christina H Liu; Jinsheng Yang; Jia Q Ren; Charng-Ming Liu; Zerong You; Philip K Liu
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

Review 3.  Glial contributions to neurodegeneration in tauopathies.

Authors:  Cheryl E G Leyns; David M Holtzman
Journal:  Mol Neurodegener       Date:  2017-06-29       Impact factor: 14.195

4.  Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration.

Authors:  Ngan Pan Bennett Au; Chi Him Eddie Ma
Journal:  Front Aging Neurosci       Date:  2017-05-04       Impact factor: 5.750

5.  A revisit of rod microglia in preclinical studies.

Authors:  Yanxia Rao; Yu-Xiang Liang; Bo Peng
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

Review 6.  Intersection of pathological tau and microglia at the synapse.

Authors:  Thomas Vogels; Adriana-Natalia Murgoci; Tomáš Hromádka
Journal:  Acta Neuropathol Commun       Date:  2019-07-05       Impact factor: 7.801

7.  A Model of Chronic Temporal Lobe Epilepsy Presenting Constantly Rhythmic and Robust Spontaneous Seizures, Co-morbidities and Hippocampal Neuropathology.

Authors:  Dinesh Upadhya; Maheedhar Kodali; Daniel Gitai; Olagide W Castro; Gabriele Zanirati; Raghavendra Upadhya; Sahithi Attaluri; Eeshika Mitra; Bing Shuai; Bharathi Hattiangady; Ashok K Shetty
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

Review 8.  Cellular Biology of Tau Diversity and Pathogenic Conformers.

Authors:  Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Lenka Hromadkova; Jiri G Safar; David Westaway
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

9.  Expression of Tau40 induces activation of cultured rat microglial cells.

Authors:  Lu Wang; Qian Jiang; Jiang Chu; Li Lin; Xiao-Guang Li; Gao-Shang Chai; Qun Wang; Jian-Zhi Wang; Qing Tian
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 10.  Glial Tau Pathology in Tauopathies: Functional Consequences.

Authors:  Martha A Kahlson; Kenneth J Colodner
Journal:  J Exp Neurosci       Date:  2016-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.